Innospec

Photo
22.04.2021 • News

Elementis Rebuffs Innospec Approach

UK specialty chemicals company Elementis has been the subject of another attempted takeover – its fourth in under six months – but this time from US rival, Innospec.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.